Recommendations on the management of multiple myeloma in 2020.
Multiple myeloma
covid-19
immunotherapy
novel agents
relapse
transplantation
upfront therapy
Journal
Acta clinica Belgica
ISSN: 2295-3337
Titre abrégé: Acta Clin Belg
Pays: England
ID NLM: 0370306
Informations de publication
Date de publication:
Apr 2022
Apr 2022
Historique:
pubmed:
24
12
2020
medline:
9
3
2022
entrez:
23
12
2020
Statut:
ppublish
Résumé
With the introduction of immunomodulatory drugs, proteasome inhibitors, and anti-CD38 monoclonal antibodies, major improvements have been achieved in the treatment of multiple myeloma (MM), with a significant impact on the outcome of this disease. Different treatment combinations are now in use and other therapies are being developed. Based on an extensive review of the recent literature, we propose practical recommendations on myeloma management, to be used by hematologists as a reference for daily practice.
Identifiants
pubmed: 33355041
doi: 10.1080/17843286.2020.1860411
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM